Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10592608 | Bioorganic & Medicinal Chemistry Letters | 2014 | 4 Pages |
Abstract
The discovery of a novel series of cyclopenta[b]furans as CCR2 inhibitors is discussed. This series has excellent CCR2 potency and PK characteristics, and good cardiovascular safety.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Michael P. Winters, Christopher A. Teleha, Fu-An Kang, David McComsey, John C. O'Neill, Cuifen Hou, Thomas Kirchner, Ping Wang, Dana Johnson, Zhihua Sui,